Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Amygdala
    Junior Member
    • Sep 2019
    • 1

    #1

    Diluting Nextera XT Indexes?

    Hey all,

    My samples originate from LCM, and I am currently following the SMART-seq2 workflow. Recently one group has combined both these approaches and written a nice protocol for it: https://doi.org/10.1007/978-1-4939-7213-5_6

    Both Picelli's SMART-seq2 protocol (for single cells) and the above LCM-seq protocols mentions diluting the index adapters from the Nextera XT Index Kit, which appears to go against Illumina's protocol for adding 5ul of each adapter per sample without diluting. In the Picelli's original paper the authors do not dilute the index adapters, so I am a bit confused.

    Can anyone clear this up for me? Or explain the benefit of diluting the adapters? I would have thought that since I am adding the recommended 1ng of input material for the Nextera XT library prep kit that I would follow Illumina's protocol of not diluting the adapters.

    Many thanks!
  • kmkocot
    Member
    • Jun 2009
    • 51

    #2
    I've also been curious about this. We often have a leftover index/adapter peak in our fragment analyzer traces of Nextera XT libraries made from SMART-Seq HT cDNA. I don't have a helpful answer but it seems like a reasonable thing to do. We struggle to get ideal Nextera XT library peaks following the Illumina protocol closely so we have been scared to change the amount of adapter used, though.

    Comment

    • aurman
      Junior Member
      • May 2023
      • 1

      #3
      While I do not have any advice for your question, I was wondering if you knew the initial concentration of the Nextera XT indices. I ordered custom adaptors, but am not sure what concentration to add.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      27 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      20 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      36 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      43 views
      0 reactions
      Last Post SEQadmin2  
      Working...